BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37335295)

  • 1. Primary Urethra Non-Hodgkin Lymphoma in a 46-Year-Old Man on FDG PET/CT.
    Zhao W; Li P; Li Y; He Y; Yang J
    Clin Nucl Med; 2023 Aug; 48(8):725-726. PubMed ID: 37335295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT.
    Ribeiro TH; S R; Castro AC; Paulino E; Mamede M
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):109-111. PubMed ID: 28355370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of
    Jitani AK; Dutta S; Mandal PK; De R; Jajodia E; Baul S; Chakrabarti P; Dolai TK
    Indian J Med Res; 2021 May; 154(5):691-698. PubMed ID: 35532587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
    Ömür Ö; Baran Y; Oral A; Ceylan Y
    Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Breast Lymphoma Mimicking Metastatic Breast Cancer on 18F-FDG PET-CT.
    Usmani S; Albader FL; Marafi F; Elhaggracy RS
    J Pak Med Assoc; 2022 Jun; 72(6):1241-1242. PubMed ID: 35751349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression.
    Lee I; Lim I; Lee KC; Kang HJ; Lim SM
    Clin Nucl Med; 2023 Feb; 48(2):e82-e83. PubMed ID: 36127796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Solitary Laryngotracheal Lymphoma Evaluated by 18F-FDG PET/CT.
    Wang Q; Tang W; Yang S; Chen Y
    Clin Nucl Med; 2021 Aug; 46(8):686-687. PubMed ID: 33782279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of Diffuse Large B-Cell Lymphoma of the Prostate on 18F-FDG PET-CT.
    Usmani S; Ahmed DAT; Hamadah A; Al Kandari F
    J Pak Med Assoc; 2021 Jan; 71(1(B)):388-389. PubMed ID: 35157690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.
    Broski SM; Bou-Assaly W; Gross MD; Fig LM
    Clin Nucl Med; 2009 Apr; 34(4):251-3. PubMed ID: 19300063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 FDG PET/CT in primary tonsillar lymphoma.
    Zhang MJ; Jiang JJ; Jiang MS; He W
    Clin Nucl Med; 2010 Sep; 35(9):710-2. PubMed ID: 20706049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tamayo P; Martín A; Díaz L; Cabrero M; García R; García-Talavera P; Caballero D
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):312-321. PubMed ID: 28483374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of 18F-FDG PET/CT for evaluating response of ocular adnexal lymphoma to treatment.
    Fujii H; Tanaka H; Nomoto Y; Harata N; Oota S; Isogai J; Yoshida K
    Medicine (Baltimore); 2018 Apr; 97(17):e0543. PubMed ID: 29703034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
    Pelosi E; Pregno P; Penna D; Deandreis D; Chiappella A; Limerutti G; Vitolo U; Mancini M; Bisi G; Gallo E
    Radiol Med; 2008 Jun; 113(4):578-90. PubMed ID: 18414808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare involvement of diffuse large B-cell lymphoma: Peritoneal lymphomatosis with a peritoneal super-scan appearance on
    Yılmaz F; Önner H
    Hell J Nucl Med; 2022; 25(1):103-105. PubMed ID: 35388807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on
    Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S
    Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
    Dräger DL; Heuschkel M; Protzel C; Erbersdobler A; Krause BJ; Hakenberg OW; Schwarzenböck SM
    Nuklearmedizin; 2018 Feb; 57(1):26-30. PubMed ID: 29536497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Kandeel AA; Hussein M; Zidan L; Younis J; Edesa W; Alsayed Y
    Nucl Med Commun; 2020 Mar; 41(3):269-279. PubMed ID: 31895758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.